UKProfiles


Profiles Research Networking Software

Keywords
Last Name
Institution

Vivek Rangnekar

Address1100 Veterans Drive
309 COMBS BUILDING
LEXINGTON KY 405360096
Phone8592572677
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hebbar N, Wang C, Rangnekar VM. Mechanisms of apoptosis by the tumor suppressor Par-4. J Cell Physiol. 2012 Dec; 227(12):3715-21. PMID: 22552839.
      View in: PubMed
    2. Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM, Horbinski C, Rangnekar VM. Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4. Cancer Res. 2013 Jan 15; 73(2):1011-9. PMID: 23204231.
      View in: PubMed
    3. Warren GW, Romano MA, Kudrimoti MR, Randall ME, McGarry RC, Singh AK, Rangnekar VM. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. 2012 Dec 1; 131(11):2519-27. PMID: 22447412.
      View in: PubMed
    4. Warren GW, Arnold SM, Valentino JP, Gal TJ, Hyland AJ, Singh AK, Rangnekar VM, Cummings KM, Marshall JR, Kudrimoti MR. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol. 2012 Apr; 103(1):45-8. PMID: 22119370.
      View in: PubMed
    5. Zhao Y, Burikhanov R, Brandon J, Qiu S, Shelton BJ, Spear B, Bondada S, Bryson S, Rangnekar VM. Systemic Par-4 inhibits non-autochthonous tumor growth. Cancer Biol Ther. 2011 Jul 15; 12(2):152-7. PMID: 21613819.
      View in: PubMed
    6. Shrestha-Bhattarai T, Rangnekar VM. Cancer-selective apoptotic effects of extracellular and intracellular Par-4. Oncogene. 2010 Jul 8; 29(27):3873-80. PMID: 20440265.
      View in: PubMed
    7. Schwarze S, Rangnekar VM. Targeting plasma membrane GRP78 for cancer growth inhibition. Cancer Biol Ther. 2010 Jan; 9(2):153-5. PMID: 20026905.
      View in: PubMed
    8. Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell. 2009 Jul 23; 138(2):377-88. PMID: 19632185.
      View in: PubMed
    9. Park S, Zhao D, Hatanpaa KJ, Mickey BE, Saha D, Boothman DA, Story MD, Wong ET, Burma S, Georgescu MM, Rangnekar VM, Chauncey SS, Habib AA. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res. 2009 May 15; 69(10):4107-11. PMID: 19435890.
      View in: PubMed
    10. Zhao Y, Rangnekar VM. Apoptosis and tumor resistance conferred by Par-4. Cancer Biol Ther. 2008 Dec; 7(12):1867-74. PMID: 18836307.
      View in: PubMed
    11. Azmi AS, Wang Z, Burikhanov R, Rangnekar VM, Wang G, Chen J, Wang S, Sarkar FH, Mohammad RM. Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis. Mol Cancer Ther. 2008 Sep; 7(9):2884-93. PMID: 18790769.
      View in: PubMed
    12. Goswami A, Qiu S, Dexheimer TS, Ranganathan P, Burikhanov R, Pommier Y, Rangnekar VM. Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity. Cancer Res. 2008 Aug 1; 68(15):6190-8. PMID: 18676842.
      View in: PubMed
    13. Wheeler DL, Rangnekar VM, Schwarze SR. ErbB4 targeting approaches for prostate cancer treatment. Cancer Biol Ther. 2008 Jul; 7(7):1095-7. PMID: 18698169.
      View in: PubMed
    14. Azmi AS, Ahmad A, Banerjee S, Rangnekar VM, Mohammad RM, Sarkar FH. Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM). Pharm Res. 2008 Sep; 25(9):2117-24. PMID: 18427961.
      View in: PubMed
    15. Shareef MM, Cui N, Burikhanov R, Gupta S, Satishkumar S, Shajahan S, Mohiuddin M, Rangnekar VM, Ahmed MM. Role of tumor necrosis factor-alpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma. Cancer Res. 2007 Dec 15; 67(24):11811-20. PMID: 18089811.
      View in: PubMed
    16. Vasudevan KM, Burikhanov R, Goswami A, Rangnekar VM. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras. Cancer Res. 2007 Nov 1; 67(21):10343-50. PMID: 17974977.
      View in: PubMed
    17. Zhao Y, Burikhanov R, Qiu S, Lele SM, Jennings CD, Bondada S, Spear B, Rangnekar VM. Cancer resistance in transgenic mice expressing the SAC module of Par-4. Cancer Res. 2007 Oct 1; 67(19):9276-85. PMID: 17909035.
      View in: PubMed
    18. Sun Y, St Clair DK, Fang F, Warren GW, Rangnekar VM, Crooks PA, St Clair WH. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN. Mol Cancer Ther. 2007 Sep; 6(9):2477-86. PMID: 17876045.
      View in: PubMed
    19. Gupta V, Yeo G, Kawakubo H, Rangnekar V, Ramaswamy P, Hayashida T, MacLaughlin DT, Donahoe PK, Maheswaran S. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism. Cancer Res. 2007 Mar 15; 67(6):2747-56. PMID: 17363596.
      View in: PubMed
    20. Languino LR, Rangnekar VM. "D" approach to prevent metastasis. Cancer Biol Ther. 2007 Jan; 6(1):110-1. PMID: 17264669.
      View in: PubMed
    21. Gururajan M, Dasu T, Shahidain S, Jennings CD, Robertson DA, Rangnekar VM, Bondada S. Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. J Immunol. 2007 Jan 1; 178(1):111-21. PMID: 17182546.
      View in: PubMed
    22. Goswami A, Ranganathan P, Rangnekar VM. The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target. Cancer Res. 2006 Mar 15; 66(6):2889-92. PMID: 16540633.
      View in: PubMed
    23. Vasudevan KM, Ranganathan P, Rangnekar VM. Regulation of Par-4 by oncogenic Ras. Methods Enzymol. 2006; 407:422-42. PMID: 16757343.
      View in: PubMed
    24. Ranganathan P, Rangnekar VM. Regulation of cancer cell survival by Par-4. Ann N Y Acad Sci. 2005 Nov; 1059:76-85. PMID: 16382046.
      View in: PubMed
    25. Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T, Rangnekar VM. Binding and phosphorylation of par-4 by akt is essential for cancer cell survival. Mol Cell. 2005 Oct 7; 20(1):33-44. PMID: 16209943.
      View in: PubMed
    26. Ranganathan P, Rangnekar VM. Exploiting the TSA connections to overcome apoptosis-resistance. Cancer Biol Ther. 2005 Apr; 4(4):391-2. PMID: 15908800.
      View in: PubMed
    27. Pruitt K, Ulkü AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem. 2005 Jun 17; 280(24):23363-70. PMID: 15831492.
      View in: PubMed
    28. Gurumurthy S, Goswami A, Vasudevan KM, Rangnekar VM. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol Cell Biol. 2005 Feb; 25(3):1146-61. PMID: 15657440.
      View in: PubMed
    29. Gurumurthy S, Rangnekar VM. Par-4 inducible apoptosis in prostate cancer cells. J Cell Biochem. 2004 Feb 15; 91(3):504-12. PMID: 14755681.
      View in: PubMed
    30. Vasudevan KM, Gurumurthy S, Rangnekar VM. Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol. 2004 Feb; 24(3):1007-21. PMID: 14729949.
      View in: PubMed
    31. Rege YD, Rangnekar VM. Molecular therapy intervention prospects in prostate cancer. Curr Pharm Des. 2004; 10(5):523-30. PMID: 14965337.
      View in: PubMed
    32. El-Guendy N, Zhao Y, Gurumurthy S, Burikhanov R, Rangnekar VM. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol Cell Biol. 2003 Aug; 23(16):5516-25. PMID: 12897127.
      View in: PubMed
    33. Yang CC, Lin HP, Chen CS, Yang YT, Tseng PH, Rangnekar VM, Chen CS. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells. J Biol Chem. 2003 Jul 11; 278(28):25872-8. PMID: 12738789.
      View in: PubMed
    34. Butler J, Rangnekar VM. Par-4 for molecular therapy of prostate cancer. Curr Drug Targets. 2003 Apr; 4(3):223-30. PMID: 12643472.
      View in: PubMed
    35. Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem. 2003 May 30; 278(22):19995-20005. PMID: 12644474.
      View in: PubMed
    36. El-Guendy N, Rangnekar VM. Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp Cell Res. 2003 Feb 1; 283(1):51-66. PMID: 12565819.
      View in: PubMed
    37. Longenecker G, Thyagarajan T, Nagineni CN, Flanders KC, Factor V, Miller G, Ward JM, Nalca A, Rangnekar VM, Thorgeirsson S, Kulkarni AB. Endocrine expression of the active form of TGF-beta1 in the TGF-beta1 null mice fails to ameliorate lethal phenotype. Cytokine. 2002 Apr 7; 18(1):43-50. PMID: 12090759.
      View in: PubMed
    38. Boehrer S, Chow KU, Beske F, Kukoc-Zivojnov N, Puccetti E, Ruthardt M, Baum C, Rangnekar VM, Hoelzer D, Mitrou PS, Weidmann E. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation. Cancer Res. 2002 Mar 15; 62(6):1768-75. PMID: 11912153.
      View in: PubMed
    39. Rangnekar VM. Art of excellence in scientific research. Cancer Biol Ther. 2002 Jan-Feb; 1(1):72-3. PMID: 12170766.
      View in: PubMed
    40. Chakraborty M, Qiu SG, Vasudevan KM, Rangnekar VM. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res. 2001 Oct 1; 61(19):7255-63. PMID: 11585763.
      View in: PubMed
    41. Lucas T, Pratscher B, Krishnan S, Fink D, Günsberg P, Wolschek M, Wacheck V, Muster T, Romirer I, Wolff K, Pehamberger H, Eichler HG, Rangnekar VM, Jansen B. Differential expression levels of Par-4 in melanoma. Melanoma Res. 2001 Aug; 11(4):379-83. PMID: 11479426.
      View in: PubMed
    42. Porntadavity S, Xu Y, Kiningham K, Rangnekar VM, Prachayasittikul V, Prachayasitikul V, St Clair DK. TPA-activated transcription of the human MnSOD gene: role of transcription factors Sp-1 and Egr-1. DNA Cell Biol. 2001 Aug; 20(8):473-81. PMID: 11560779.
      View in: PubMed
    43. Dhillon HS, Dong GX, Yurek DM, Estus S, Rangnekar VM, Dendle P, Prasad RM. Regional expression of Par-4 mRNA and protein after fluid percussion brain injury in the rat. Exp Neurol. 2001 Jul; 170(1):140-8. PMID: 11421591.
      View in: PubMed
    44. Boehrer S, Chow KU, Puccetti E, Ruthardt M, Godzisard S, Krapohl A, Schneider B, Hoelzer D, Mitrou PS, Rangnekar VM, Weidmann E. Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia. Hematol J. 2001; 2(2):103-7. PMID: 11424002.
      View in: PubMed
    45. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 2001; 20(3-4):225-43. PMID: 12085964.
      View in: PubMed
    46. Das A, Chendil D, Dey S, Mohiuddin M, Mohiuddin M, Milbrandt J, Rangnekar VM, Ahmed MM. Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis. J Biol Chem. 2001 Feb 2; 276(5):3279-86. PMID: 11035041.
      View in: PubMed
    47. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem. 2000 Apr 14; 275(15):11397-403. PMID: 10753955.
      View in: PubMed
    48. Page G, Kögel D, Rangnekar V, Scheidtmann KH. Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis. Oncogene. 1999 Dec 2; 18(51):7265-73. PMID: 10602480.
      View in: PubMed
    49. Qiu SG, Krishnan S, el-Guendy N, Rangnekar VM. Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation. Oncogene. 1999 Nov 25; 18(50):7115-23. PMID: 10597313.
      View in: PubMed
    50. Nalca A, Qiu SG, El-Guendy N, Krishnan S, Rangnekar VM. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J Biol Chem. 1999 Oct 15; 274(42):29976-83. PMID: 10514481.
      View in: PubMed
    51. Kruman II, Nath A, Maragos WF, Chan SL, Jones M, Rangnekar VM, Jakel RJ, Mattson MP. Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. Am J Pathol. 1999 Jul; 155(1):39-46. PMID: 10393834.
      View in: PubMed
    52. Duan W, Rangnekar VM, Mattson MP. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J Neurochem. 1999 Jun; 72(6):2312-22. PMID: 10349840.
      View in: PubMed
    53. Cook J, Krishnan S, Ananth S, Sells SF, Shi Y, Walther MM, Linehan WM, Sukhatme VP, Weinstein MH, Rangnekar VM. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma. Oncogene. 1999 Feb 4; 18(5):1205-8. PMID: 10022126.
      View in: PubMed
    54. Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4. Oncogene. 1999 Jan 21; 18(3):623-31. PMID: 9989812.
      View in: PubMed
    55. Nalca A, Rangnekar VM. The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/WAF1 function. J Biol Chem. 1998 Nov 13; 273(46):30517-23. PMID: 9804820.
      View in: PubMed
    56. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM, Mattson MP. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat Med. 1998 Aug; 4(8):957-62. PMID: 9701251.
      View in: PubMed
    57. Rangnekar VM. Apoptosis mediated by a novel leucine zipper protein Par-4. Apoptosis. 1998 Mar; 3(2):61-6. PMID: 14646502.
      View in: PubMed
    58. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 1998 Jan-Feb; 5(1):3-28. PMID: 9476963.
      View in: PubMed
    59. Ahmed MM, Sells SF, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Harp C, Mohiuddin M, Rangnekar VM. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. J Biol Chem. 1997 Dec 26; 272(52):33056-61. PMID: 9407088.
      View in: PubMed
    60. Muthukkumar S, Han SS, Rangnekar VM, Bondada S. Role of Egr-1 gene expression in B cell receptor-induced apoptosis in an immature B cell lymphoma. J Biol Chem. 1997 Oct 31; 272(44):27987-93. PMID: 9346950.
      View in: PubMed
    61. Nair P, Muthukkumar S, Sells SF, Han SS, Sukhatme VP, Rangnekar VM. Early growth response-1-dependent apoptosis is mediated by p53. J Biol Chem. 1997 Aug 8; 272(32):20131-8. PMID: 9242687.
      View in: PubMed
    62. Boghaert ER, Sells SF, Walid AJ, Malone P, Williams NM, Weinstein MH, Strange R, Rangnekar VM. Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues. Cell Growth Differ. 1997 Aug; 8(8):881-90. PMID: 9269897.
      View in: PubMed
    63. Sells SF, Han SS, Muthukkumar S, Maddiwar N, Johnstone R, Boghaert E, Gillis D, Liu G, Nair P, Monnig S, Collini P, Mattson MP, Sukhatme VP, Zimmer SG, Wood DP, McRoberts JW, Shi Y, Rangnekar VM. Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol Cell Biol. 1997 Jul; 17(7):3823-32. PMID: 9199316.
      View in: PubMed
    64. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol. 1996 Dec; 16(12):6945-56. PMID: 8943350.
      View in: PubMed
    65. Ahmed MM, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Wood DP, Sells SF, Mohiuddin M, Rangnekar VM. EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells. J Biol Chem. 1996 Nov 15; 271(46):29231-7. PMID: 8910582.
      View in: PubMed
    66. Muthukkumar S, Sells SF, Crist SA, Rangnekar VM. Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB. J Biol Chem. 1996 Mar 8; 271(10):5733-40. PMID: 8621439.
      View in: PubMed
    67. Jensen SL, Wood DP, Banks ER, Veron M, Lascu I, McRoberts JW, Rangnekar VM. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate. World J Urol. 1996; 14 Suppl 1:S21-5. PMID: 8738406.
      View in: PubMed
    68. Muthukkumar S, Nair P, Sells SF, Maddiwar NG, Jacob RJ, Rangnekar VM. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol Cell Biol. 1995 Nov; 15(11):6262-72. PMID: 7565779.
      View in: PubMed
    69. McGillis JP, Rangnekar V, Ciallella JR. A role for calcitonin gene related peptide (CGRP) in the regulation of early B lymphocyte differentiation. Can J Physiol Pharmacol. 1995 Jul; 73(7):1057-64. PMID: 8846401.
      View in: PubMed
    70. Sells SF, Muthukumar S, Sukhatme VP, Crist SA, Rangnekar VM. The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest. Mol Cell Biol. 1995 Feb; 15(2):682-92. PMID: 7823937.
      View in: PubMed
    71. Wood DP, Banks ER, Humphreys S, McRoberts JW, Rangnekar VM. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer. 1994 Nov 1; 74(9):2533-40. PMID: 7522952.
      View in: PubMed
    72. Wood DP, Banks ER, Humphreys S, Rangnekar VM. Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J Histochem Cytochem. 1994 Apr; 42(4):505-11. PMID: 7510319.
      View in: PubMed
    73. Sells SF, Wood DP, Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA, Humphreys S, Rangnekar VM. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ. 1994 Apr; 5(4):457-66. PMID: 8043520.
      View in: PubMed
    74. Mullins MW, Ciallella J, Rangnekar V, McGillis JP. Characterization of a calcitonin gene-related peptide (CGRP) receptor on mouse bone marrow cells. Regul Pept. 1993 Nov 19; 49(1):65-72. PMID: 8278635.
      View in: PubMed
    75. McGillis JP, Humphreys S, Rangnekar V, Ciallella J. Modulation of B lymphocyte differentiation by calcitonin gene-related peptide (CGRP). II. Inhibition of LPS-induced kappa light chain expression by CGRP. Cell Immunol. 1993 Sep; 150(2):405-16. PMID: 8396499.
      View in: PubMed
    76. McGillis JP, Humphreys S, Rangnekar V, Ciallella J. Modulation of B lymphocyte differentiation by calcitonin gene-related peptide (CGRP). I. Characterization of high-affinity CGRP receptors on murine 70Z/3 cells. Cell Immunol. 1993 Sep; 150(2):391-404. PMID: 8396498.
      View in: PubMed
    77. Joshi-Barve SS, Rangnekar VV, Sells SF, Rangnekar VM. Interleukin-1-inducible expression of gro-beta via NF-kappa B activation is dependent upon tyrosine kinase signaling. J Biol Chem. 1993 Aug 25; 268(24):18018-29. PMID: 7688736.
      View in: PubMed
    78. Rangnekar VV, Waheed S, Rangnekar VM. Interleukin-1-inducible tumor growth arrest is characterized by activation of cell type-specific "early" gene expression programs. J Biol Chem. 1992 Mar 25; 267(9):6240-8. PMID: 1372901.
      View in: PubMed
    79. Rangnekar VV, Waheed S, Davies TJ, Toback FG, Rangnekar VM. Antimitogenic and mitogenic actions of interleukin-1 in diverse cell types are associated with induction of gro gene expression. J Biol Chem. 1991 Feb 5; 266(4):2415-22. PMID: 1989993.
      View in: PubMed
    80. Rangnekar VM, Aplin AC, Sukhatme VP. The serum and TPA responsive promoter and intron-exon structure of EGR2, a human early growth response gene encoding a zinc finger protein. Nucleic Acids Res. 1990 May 11; 18(9):2749-57. PMID: 2111009.
      View in: PubMed
    81. Soltys PA, Mazzone T, Wissler RW, Vahed S, Rangnekar V, Lukens J, Vesselinovitch D, Getz GS. Effects of feeding fish oil on the properties of lipoproteins isolated from rhesus monkeys consuming an atherogenic diet. Atherosclerosis. 1989 Apr; 76(2-3):103-15. PMID: 2730707.
      View in: PubMed
    82. Rangnekar VM, Plate JM. Interleukin-1 receptor-like proteins synthesized by translation, in vitro, of immunopurified polysomal messenger RNA. J Biol Chem. 1988 Nov 5; 263(31):16414-20. PMID: 2972710.
      View in: PubMed
    83. Rangnekar VM, Thomas LS, Plate JM. Immunoprecipitation of interleukin-1 receptors from a mouse thymoma cell line, EL-4. J Biol Chem. 1988 Nov 5; 263(31):16408-13. PMID: 2972709.
      View in: PubMed
    84. Rangnekar VM. Variation in the ability of Pseudomonas sp. strain B13 cultures to utilize meta-chlorobenzoate is associated with tandem amplification and deamplification of DNA. J Bacteriol. 1988 Apr; 170(4):1907-12. PMID: 2832387.
      View in: PubMed
    85. Rangnekar VM, Banker DD, Jhala HI. The distribution of R-plasmids in various O-antigen types of Escherichia coli from human sources. Indian J Pathol Microbiol. 1984 Apr; 27(2):67-73. PMID: 6210251.
      View in: PubMed
    86. Rangnekar VM, Banker DD, Jhala HI. Phenotypic traits of drug resistance plasmids from human isolates of Escherichia coli & Salmonella typhimurium. Indian J Med Res. 1983 Dec; 78:758-64. PMID: 6370852.
      View in: PubMed
    87. Rangnekar VM, Banker DD, Jhala HI. Some phenotypic characteristics of group H plasmids from human isolates of Salmonella & Escherichia coli. Indian J Med Res. 1983 Oct; 78:450-3. PMID: 6365757.
      View in: PubMed
    88. Telang VP, Rangnekar VM, Banker DD. Klebocin types & antimicrobial resistance of clinical isolates of Klebsiella pneumoniae at Bombay. Indian J Med Res. 1983 Sep; 78:331-6. PMID: 6370848.
      View in: PubMed
    89. Rangnekar VM, Banker DD, Jhala HI. Genetic characters of R-plasmids in Salmonella typhimurium isolated during a protracted outbreak at Bombay. Indian J Med Res. 1983 Feb; 77:169-71. PMID: 6345349.
      View in: PubMed
    90. Rangnekar VM, Banker DD, Jhala HI. Antimicrobial resistance and incompatibility groups of R plasmids in Salmonella typhimurium isolated from human sources in Bombay from 1978 to 1980. Antimicrob Agents Chemother. 1983 Jan; 23(1):54-8. PMID: 6338820.
      View in: PubMed
    91. Rangnekar VM, Banker DD, Jhala HI. Antimicrobial resistance and R-plasmids of Salmonella paratyphi A isolated at Bombay. Indian J Med Res. 1983 Jan; 77:5-9. PMID: 6862560.
      View in: PubMed
    92. Rangnekar VM, Banker DD, Jhala HI. Genetic characterization of R-plasmids from drug resistant Salmonella wien isolated at Bombay. Indian J Med Res. 1982 Nov; 76:662-7. PMID: 7166359.
      View in: PubMed
    93. Rangnekar VM, Gadre SV, Mukerji S, Chitnis DS. Genetic stability of IncH1 and other incompatibility group R-plasmids in Salmonella typhi. Indian J Med Res. 1982 Oct; 76:512-8. PMID: 7152559.
      View in: PubMed
    94. Rangnekar VM, Gadre SV, Mukerji S, Chitnis DS. Effect of some gut-associated factors on in vitro conjugal transfer of R-plasmids to Salmonella typhi. Indian J Pathol Microbiol. 1982 Oct; 25(4):253-8. PMID: 7166380.
      View in: PubMed
    95. Rangnekar VM, Banker DD, Jhala HI. R-plasmids in Salmonella oranienburg isolated from hospital outbreak. Indian J Med Res. 1982 Sep; 76:353-7. PMID: 7174027.
      View in: PubMed
    96. Rangnekar VM, Banker DD, Jhala HI. Drug resistance and incompatibility groups of R-plasmids in intestinal Escherichia coli. Indian J Med Res. 1982 Apr; 75:492-500. PMID: 6749674.
      View in: PubMed
    97. Rangnekar VM, Banker DD, Jhaia HI. Related R-plasmids in coexisting cultures of Salmonella typhimurium and Escherichia coli. Indian J Pathol Microbiol. 1982 Apr; 25(2):117-28. PMID: 6754590.
      View in: PubMed
    98. Rangnekar VM, Banker DD, Jhala HI. Plasmid-mediated multidrug resistance in Salmonella typhi. Lancet. 1981 Aug 15; 2(8242):364. PMID: 6115137.
      View in: PubMed
    Rangnekar's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description